Atherosclerotic Plaque Formation and Progression

Atherosclerotic plaque forms through the retention of lipids in the arterial wall together with endothelial dysfunction and a chronic inflammatory response. Over years it evolves from early fatty streaks into mature, fibrous, and sometimes calcified lesions, and its composition — not merely its size — determines how stable or rupture-prone it becomes.

Definition

Atherosclerotic plaque formation is the progressive accumulation in the arterial intima of lipids, inflammatory cells, smooth-muscle cells, and extracellular matrix, producing lesions that narrow the lumen and may become prone to rupture or erosion.

Scope

This topic covers atherogenesis as a biological process: lipid entry and modification, endothelial activation, monocyte recruitment and foam-cell formation, smooth-muscle migration and fibrous-cap synthesis, and the features that distinguish stable from vulnerable plaque. It is a mechanistic, non-clinical entry that underpins the rest of the coronary artery disease area.

Key concepts

• Endothelial dysfunction and activation
• LDL retention and oxidative modification
• Monocyte recruitment and foam-cell formation
• Fatty streak
• Smooth-muscle migration and fibrous cap
• Necrotic lipid core
• Vulnerable (rupture-prone) versus stable plaque
• Calcification and positive remodeling

Key theories

Response-to-injury / inflammatory hypothesis

Atherosclerosis is understood as a chronic inflammatory response to endothelial injury and dysfunction, in which retained and modified lipoproteins trigger leukocyte recruitment and a self-sustaining inflammatory process within the arterial wall rather than a passive lipid-storage phenomenon.

Mechanisms

Plaque begins where disturbed flow and risk factors cause endothelial dysfunction, allowing low-density lipoprotein to enter and be retained in the intima, where it is oxidatively modified. Modified lipoproteins and adhesion molecules recruit monocytes, which become macrophages and ingest lipid to form foam cells, the cellular basis of the fatty streak. Smooth-muscle cells migrate from the media and synthesise extracellular matrix, forming a fibrous cap over a growing lipid and necrotic core. Ongoing inflammation, matrix degradation, and cap thinning produce a vulnerable plaque whose disruption can trigger thrombosis. Plaque growth is accompanied by remodeling and, in advanced lesions, calcification.

Clinical relevance

Plaque biology explains why coronary artery disease is both a chronic and an episodic disease and why lesion composition, not only the degree of stenosis, governs the risk of acute events. This entry describes mechanisms for educational reference and does not address diagnosis, imaging thresholds, or treatment of individual patients.

Epidemiology

Atherosclerosis is near-universal in older adults in many populations and begins decades before clinical disease, with the pace of progression strongly influenced by lipid levels, smoking, hypertension, diabetes, and inflammation.

History

Nineteenth-century pathologists framed atherosclerosis largely in terms of lipid encrustation and thrombosis. Through the late twentieth century the response-to-injury concept and accumulating cell biology reframed it as an inflammatory disease of the arterial wall, and the recognition of the vulnerable plaque shifted attention from luminal narrowing alone to plaque composition and stability.

Debates

What makes a plaque rupture-prone?

Research has emphasised thin-cap fibroatheroma with a large necrotic core and active inflammation as the classic vulnerable lesion, but many infarctions arise from plaque erosion rather than rupture, and identifying which plaques will cause events prospectively remains difficult.

Key figures

• Russell Ross
• Peter Libby
• Goran K. Hansson
• Michael A. Gimbrone

Seminal works

• ross-1999
• hansson-2005
• libby-2019

Frequently asked questions

Does the largest plaque cause the most heart attacks?

Not necessarily. Many acute events arise from plaques that are not the most severely stenotic; the composition and stability of a plaque — such as a thin fibrous cap over a large lipid core — are important determinants of rupture risk.

Why is atherosclerosis called an inflammatory disease?

Because immune cells and inflammatory signalling are central to every stage of plaque development, from the recruitment of monocytes into the early lesion to the cap thinning that precedes rupture, rather than the lesion being simply a passive deposit of fat.